EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations

June Ho Chang iD, Yoo Jin Jang iD, Se Chang Yoon iD, Ji Hyun An iD, Jung-Seok Choi iD, Hong Jin Jeon iD

Clinical Psychopharmacology and Neuroscience · 31.05.2026 · 24 (2) · 240-251

DOI: 10.9758/cpn.25.1382 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 06.04.2026. Verfasst von June Ho Chang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Digital psychiatry has rapidly expanded with the integration of immersive technologies such as virtual reality (VR) and augmented reality (AR). These modalities allow for controlled, engaging, and ecologically valid interventions across a wide range of psychiatric disorders. In this review, a narrative synthesis was conducted based on systematic reviews, meta-analyses, and randomized controlled trials identified through PubMed, Google Scholar, complemented by seminal earlier works. VR-based therapies demonstrated robust efficacy for anxiety disorders and phobias, with meta-analytic evidence supporting large effect sizes. For post-traumatic stress disorder virtual reality exposure therapy was superior to waitlist control and comparable to established psychotherapies, although AR exposure therapy remains underexplored. In autism spectrum disorder, VR and AR interventions significantly enhanced cognitive, social, and communication skills. AR applications have additionally been validated for cognitive assessment in Alzheimer's disease, and VR/AR-supported rehabilitation showed promise in attention deficit hyperactivity disorder and neurodevelopmental disorders. Despite encouraging findings, challenges remain, including small sample sizes, short follow-up periods, heterogeneity of protocols, and risks such as cybersickness or fatigue. VR and AR represent innovative tools with growing empirical support across psychiatric practice, extending from diagnostic assessment to therapeutic and rehabilitative interventions. Standardized protocols, large-scale trials, and long-term outcome studies are needed to integrate these technologies into routine clinical care.

Schlagwörter

Stichwörter der Autor:innen

Anxiety disordersAugmented realityDigital healthPsychiatryVirtual reality

Autor:innen und Institutionen

  • Department of Psychiatry, Depression Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Digital Therapeutics Research Center, Samsung Medical Center, Seoul, Korea.
  • Meditrix Co., Ltd., Seoul, Korea.
  • Department of Health Sciences & Technology, Department of Medical Device Management & Research, and Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHS…

ORCID-Profile: June Ho Chang, Yoo Jin Jang, Se Chang Yoon, Ji Hyun An, Jung-Seok Choi, Hong Jin Jeon

Zitieren

APA

Chang, J. H., Jang, Y. J., Yoon, S. C., An, J. H., Choi, J. S., & Jeon, H. J. (2026). Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations. Clinical Psychopharmacology and Neuroscience, 24(2), 240-251. https://doi.org/10.9758/cpn.25.1382

Vancouver

Chang JH, Jang YJ, Yoon SC, An JH, Choi JS, Jeon HJ. Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations. Clinical Psychopharmacology and Neuroscience. 2026;24(2):240-251. doi:10.9758/cpn.25.1382

BibTeX
@article{Chang2026,
  author = {Chang, June Ho and Jang, Yoo Jin and Yoon, Se Chang and An, Ji Hyun and Choi, Jung-Seok and Jeon, Hong Jin},
  title = {Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations},
  journal = {Clinical Psychopharmacology and Neuroscience},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {240--251},
  doi = {10.9758/cpn.25.1382}
}
Kostenlos starten →